Sign inJoin waitlistJoin the waitlist

Emily Ayers

Assistant Professor, Medicine: Hematology and Oncology · University of Virginia Medical Center

Credentials: · · · · · ·

History

University of Virginia Medical Center
Present
University of Virginia Medical Center
Present

Hospital of the University of Pennsylvania
2018–2020
Hematology and Medical Oncology
University of Pennsylvania Health System
2017–2020
University of Pennsylvania
2014–2017
Columbia Univ Coll of Phys & Surgeons
2010–2014

Research

Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma
JCI Insight · 2018 · 143 citations
Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic
American Journal of Clinical Dermatology · 2013 · 117 citations
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
Blood · 2022 · 81 citations

Daniel Landsburg
12 papers
Adam Olszewski
8 papers
Reem Karmali
7 papers
David Bond
6 papers
Brian Hill
5 papers
Craig Portell
5 papers
Jeffrey Medeiros
5 papers
Narendranath Epperla
5 papers
Pallawi Torka
5 papers
Shaoying Li
5 papers
SB
Stefan Barta
5 papers
BK
Brad Kahl
4 papers

Clinical trials

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2027
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Site PI · Recruiting · Phase 1
National Cancer Institute (NCI)
2024–2027
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Site PI · Recruiting · Phase 2
Dipenkumar Modi
2023–2028